Abbott India Revenue Y/Y
What is the Revenue Y/Y of Abbott India?
The Revenue Y/Y of Abbott India Limited is 11.50%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NSE compared to Abbott India
What does Abbott India do?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Companies with revenue y/y similar to Abbott India
- Cipher Pharmaceuticals has Revenue Y/Y of 11.47%
- Sekisui House has Revenue Y/Y of 11.47%
- Asian Granito India has Revenue Y/Y of 11.49%
- Transport of India has Revenue Y/Y of 11.49%
- Sanken Electric Co has Revenue Y/Y of 11.50%
- ACI Worldwide Inc has Revenue Y/Y of 11.50%
- Abbott India has Revenue Y/Y of 11.50%
- Pittards plc has Revenue Y/Y of 11.50%
- Corvel has Revenue Y/Y of 11.50%
- Man Shun () has Revenue Y/Y of 11.51%
- MECOM Power and Construction has Revenue Y/Y of 11.51%
- International Stem Cell has Revenue Y/Y of 11.51%
- Nexus AG has Revenue Y/Y of 11.52%